1A04060

ROZTWÓR N-NITROZOPIROLIDYNY (NPYR)

Pharmaceutical Analytical Impurity (PAI)

• Synonim(y): N-Nitrosopyrrolidine (npyr) solution, (1 ml (1 mg/ml) (1-Nitrosopyrrolidine))
• Wzór empiryczny (zapis Hilla): C₄H₈N₂O
• Numer CAS: 930-55-2
• Masa cząsteczkowa: 100.12
• MDL number: MFCD00003166
• NACRES: NA.24
• UNSPSC Code: 41116107

Właściwości

• grade: pharmaceutical analytical impurity (PAI)
• agency: USP
• form: liquid
• manufacturer/tradename: USP
• application(s): pharmaceutical small molecule
• format: neat
• storage temp.: -10 to -25°C
• SMILES string: N1(CCCC1)N=O
• InChI key: WNYADZVDBIBLJJ-UHFFFAOYSA-N

Opis

General description

Find answers to frequently asked questions on USP products in USP FAQs.

N-Nitrosopyrrolidine (NPYR) Solution is a USP Pharmaceutical Analytical Impurity (PAI).

USP PAI are a product line of impurities suitable for research and analytical purposes, which help to ensure the quality and safety of medicines.

For more information about this PAI, visit here.

Application

N-Nitrosopyrrolidine (NPYR) Solution is intended for use in analytical testing to detect, identify, and measure pharmaceutical impurities.

Features and Benefits

USP PAI advance your early analytical R&D and process development. PAI can be used in the following applications:
1. Conduct analytical tests during early formulation feasibility studies.
2. Determine degradation impurities produced during stress studies.
3. Develop, validate, and transfer analytical methods.
4. Perform spiking studies during process R&D to demonstrate depletion upon recrystallization.
5. Record retention times and/or spectra
6. Determine relative response factors.
7. Identify unknown impurities that formed during ICH stability conditions.
8. Identify impurities that are present in the Reference Listed Drug
9. Test for and profile impurities not listed in drug substance and drug product monographs.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Other Notes

Kartę SDS wydaną przez USP można znaleźć tutaj.

Sales restrictions may apply.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• pictograms: GHS02,GHS06,GHS08
• signalword: Danger
• hcodes: H225,H301 + H311 + H331,H351,H370
• pcodes: P202 - P210 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
• Hazard Classifications: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Carc. 2 - Flam. Liq. 2 - STOT SE 1
• target_organs: Eyes,Central nervous system
• Klasa składowania: 3 - Flammable liquids
• wgk: WGK 2